Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Penn Medicine study finds lower utilization of CTC for cancer screening

In 2009, the Centers for Medicare and Medicaid Services halted reimbursement for so-called "virtual colonoscopy" for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, computed tomography colonography, was being used in the elderly population.

5 Apr 2013

Men with Lynch syndrome face increased lifetime risk of prostate cancer

Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.

2 Apr 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

Colonoscopies are number one way to discover pre-cancerous growths, SLU gastroenterologist says

According to the American Cancer Society, our lifetime risk of developing colorectal cancer is about 1 in 20. This March, join Saint Louis University to share the message that prevention can stop colorectal cancer before it starts and help us change these odds.

25 Mar 2013

Special issue on colorectal cancer published in GIE: Gastrointestinal Endoscopy journal

In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer.

20 Mar 2013

AGA, CDC partner to promote free colonoscopies for uninsured patients

Colorectal cancer (CRC) is the second leading cause of cancer deaths among men and women nationwide. During National Colorectal Cancer Awareness Month, the Centers for Disease Control and Prevention (CDC) and the American Gastroenterological Association (AGA) are joining forces for the second year to promote free colonoscopies for uninsured patients.

19 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

AMGA Distinguished Corporate Partner Award to be presented to Exact Sciences

The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on March 15 to Exact Sciences at its 2012 Annual Conference, March 14-16 at the Hilton Bonnet Creek Resort in Orlando.

16 Mar 2013

Results from GTx's Phase 2 clinical trial of enobosarm published online

GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.

15 Mar 2013

Maintaining high-quality CT colonography while reducing radiation dose is possible, finds study

A new study by a Rhode Island Hospital researcher has found it's possible to maintain high-quality CT colonography diagnostic images while reducing the radiation dose.

13 Mar 2013

NCI-sponsored study to evaluate rosuvastatin for prevention of colon cancer

With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study. This National Cancer Institute (NCI)-sponsored study evaluates the cholesterol drug, rosuvastatin (Crestor), as a treatment to reduce the risk of colon cancer.

11 Mar 2013

Screening healthy adults could potentially prevent rare genetic disorders

Millions of people unknowingly carry rare gene mutations that put them at high risk of developing preventable diseases such as colorectal cancer, breast cancer, and several catastrophic blood vessel disorders.

6 Mar 2013

Ten tips to reduce risk of colorectal cancer

With colorectal cancer the second leading cause of cancer death, it's a great time to take a look at the health of your colon. "Colorectal cancer surpasses breast and prostate cancers as a leading cause of cancer death in men and women," said Dr. James Yoo, assistant professor of surgery and chief of the colon & rectal surgery program at the David Geffen School of Medicine at UCLA. "It is largely preventable with early screening and detection."

5 Mar 2013

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon.

4 Mar 2013

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.

4 Mar 2013

Electronic health records increase colorectal cancer screening rates

Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum-and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening-and saved health costs-over two years.

4 Mar 2013

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Sanofi and Regeneron Pharmaceuticals, Inc. announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting the alpha subunit of the interleukin 4 receptor (IL-4R alpha), were presented at the 71st Annual Meeting of the American Academy of Dermatology (AAD) in Miami.

4 Mar 2013

Colonoscopy is also safe, confirms German Cancer Research Center study

Colon cancer develops slowly. Precancerous lesions usually need many years to turn into a dangerous carcinoma. They are well detectable in an endoscopic examination of the colon called colonoscopy and can be removed during the same examination. Therefore, regular screening can prevent colon cancer much better than other types of cancer.

3 Mar 2013